<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39437928</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1026</ISSN><JournalIssue CitedMedium="Internet"><Volume>955</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>The Science of the total environment</Title><ISOAbbreviation>Sci Total Environ</ISOAbbreviation></Journal><ArticleTitle>Exploring hepatitis A dynamics in Israel, 2019-2022.</ArticleTitle><Pagination><StartPage>176861</StartPage><MedlinePgn>176861</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scitotenv.2024.176861</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0048-9697(24)07018-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Continuous monitoring of Hepatitis A Virus (HAV) may assist in identifying local outbreaks. The advent of the COVID-19 pandemic, which affected the circulation of numerous pathogens, may have also impacted the scope of HAV infections.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To investigate the incidence and environmental dissemination of HAV between 2019 and 2022 in Israel, a country with an anti-HAV vaccination program.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">HAV RT-PCR analysis was performed for all HAV cases and for 280 sewage samples collected in 2019-2022. Available amplified HAV fragments from clinical (n = 107) and sewage (n = 27) were also assessed by genotyping and phylogenetic analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2019-2022, 158 individuals and 12.9 % (36/280) of sewage samples were HAV-RNA positive. Median age was 30 years (IQR 20.5-44); approximately half (51.9 %, 82/158) were males. Almost all patients (98.4 %, 124/126) were not vaccinated. Highest numbers were identified in 2019 (84 cases and 30 %, 21/71, positive sewage samples). In 2020, when three COVID-19 related lockdowns were implemented, 24 cases and 4.3 % (3/69) sewage samples were HAV-RNA positive. The number of HAV-RNA positive cases and positive sewage samples remained low in 2021-2022 (31 and 19 cases, 13.2 %, 9/68 and 4.2 %, 3/72 positive sewage samples, respectively). Sub-genotype IB dominated (90.7 %, 97/107 of cases and 81.5 %, 22/27 of sewage samples), and phylogenetic analysis of HAV samples demonstrated small transmission clusters of sequences from Jews, Bedouin Arabs and foreign workers. Sub-genotype IA was identified in 8.4 % (9/107) of cases and in 18.5 % (5/27) of sewage samples.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Combined clinical and environmental surveillance is optimal for monitoring HAV. In 2020, the circulation of HAV decreased, possibly following COVD-19 health restrictions. In subsequent years, the incidence remained low. Adults in risk-groups for HAV infection should be vaccinated to minimize HAV circulation.</AbstractText><CopyrightInformation>Copyright © 2024 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gozlan</LastName><ForeName>Yael</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Central Virology Laboratory, Ministry of Health, Israel; Faculty of Medicine, Tel-Aviv University, Israel. Electronic address: Yael.Gozlan@sheba.health.gov.il.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuckerman</LastName><ForeName>Neta S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Central Virology Laboratory, Ministry of Health, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yizchaki</LastName><ForeName>Mayyan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Central Virology Laboratory, Ministry of Health, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rich</LastName><ForeName>Rivka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Ministry of Health, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bar-Or</LastName><ForeName>Itay</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Central Virology Laboratory, Ministry of Health, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mor</LastName><ForeName>Orna</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Central Virology Laboratory, Ministry of Health, Israel; Faculty of Medicine, Tel-Aviv University, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Sci Total Environ</MedlineTA><NlmUniqueID>0330500</NlmUniqueID><ISSNLinking>0048-9697</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hepatitis A Virus</Keyword><Keyword MajorTopicYN="N">Surveillance</Keyword><Keyword MajorTopicYN="N">Wastewater</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>19</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39437928</ArticleId><ArticleId IdType="doi">10.1016/j.scitotenv.2024.176861</ArticleId><ArticleId IdType="pii">S0048-9697(24)07018-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle>